Condition

Metabolic Associated Fatty Liver Disease clinical trials and research

• 7Clinical trials
• 3Countries

Newest Metabolic Associated Fatty Liver Disease clinical trials

All recruiting trials (7)

• Glucagon resistance in MASLD and type 2 diabetes

  This will see if people with type 2 diabetes, with or without MASLD, respond differently to glucagon in liver fat oxidation and VLDL-triglyceride secretion.

  Recruiting University of Aarhus · Aarhus · NCT07246421

• Rifaximin treatment for metabolic-associated fatty liver disease

  This trial tests whether taking oral rifaximin for 24 weeks helps adults with metabolic-associated fatty liver disease (MAFLD) and is safe.

  Recruiting Early Phase 1 Shanghai Changzheng Hospital · Shanghai, Shanghai Municipality · NCT07185932

• New MRI methods to measure metabolism and predict outcomes in metabolic-associated fatty liver disease

  This project tests whether new MRI techniques can measure body metabolism and help predict disease status and prognosis for people with metabolic-associated fatty liver disease.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07149571

• Non-invasive blood and imaging tests for metabolic liver disease

  This project tests whether blood tests and imaging scans can diagnose and stage metabolic-associated steatohepatitis (MASH) and liver fibrosis in adults with metabolic risk factors.

  Recruiting at 4 sites Foundation for the National Institutes of Health · Miami, Florida and 3 other locations · NCT07122700

• Effects of a Low Valine Diet on Weight and Metabolism

  This study is testing if meal replacements with less valine can help overweight and obese people lose weight and improve their metabolism compared to regular meal replacements.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT06883578

• Investigating the prevalence of metabolic associated fatty liver disease in patients with type 2 diabetes in Jiangsu Province, China

  This study looks at how common fatty liver disease is in people with type 2 diabetes in Jiangsu Province, China, and how it relates to their insulin levels.

  Recruiting Wuxi Hisky Medical Technology Co Ltd · Nanjing, Jiangsu · NCT05597709

• Understanding Metabolic Associated Fatty Liver Disease in China

  This study is trying to learn more about metabolic liver disease in China by collecting health information and samples from patients to find markers that could help predict how the disease affects them.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT04573283

Related topics

Quick answers

How many Metabolic Associated Fatty Liver Disease clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (5 trials), Denmark (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →